Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 28, 2010Cancer ResearchOpen Access

The Neuroblastoma-Associated F1174L ALK Mutation Causes Resistance to an ALK Kinase Inhibitor in ALK-Translocated Cancers

View Full Paper
Ask AI
Bookmark
Share

Authors

TSTakaaki SasakiAsahikawa Medical College HospitalKOKatsuhiro OkudaNagoya City UniversityWZWei ZhengKunming Institute of Botany

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sasaki et al. (2010) studied this question.

synapsesocial.com/papers/69d89acf18b0ca7f91d186c4https://doi.org/10.1158/0008-5472.can-10-2956
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Fusion of a Kinase Gene, <i>ALK</i> , to a Nucleolar Protein Gene, <i>NPM</i> , in Non-Hodgkin's Lymphoma1994 · 2,424 citations
  2. 2Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK2006 · 383 citations
  3. 3Crizotinib in<i>ALK</i>-Rearranged Inflammatory Myofibroblastic Tumor2010 · 874 citations
  4. 4Predictors of Competing Mortality in Advanced Head and Neck Cancer2009 · 434 citations
  5. 5Clinical activity observed in a phase I dose escalation trial of an oral c-met and ALK inhibitor, PF-023410662009 · 207 citations